InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Deschatelets Pascal, Chief Scientific Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 62 reports have been published. Breakdown: 0 buy · 20 sells. Total volume traded: €10m. Activity tracked since 24 May 2021. The latest transaction was disclosed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Deschatelets Pascal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
1,177,222 sharesCommon StockSEC:0001193125-26-224609:0
25,840 shares0Common StockSEC:0001492422-26-000076:0
5,928 shares@ US$21.76540.9% of flowCommon StockSEC:0001492422-26-000058:0
909 shares@ US$19.79290.1% of flowCommon StockSEC:0001492422-26-000042:0
2,277 shares@ US$22.18720.4% of flowCommon StockSEC:0001492422-26-000029:0
12,780 shares@ US$3.760.4% of flowCommon StockSEC:0001127602-25-015285:0
826 shares@ US$29.52360.2% of flowCommon StockSEC:0001127602-25-002377:0
3,948 shares@ US$30.42551.0% of flowCommon StockSEC:0001127602-25-001833:0
750 shares@ US$29.95820.2% of flowCommon StockSEC:0001127602-25-001618:0
15,045 shares0Common StockSEC:0001127602-25-001618:1
2,288 shares@ US$28.70210.5% of flowCommon StockSEC:0001127602-25-001189:0
24,500 shares@ US$3.760.7% of flowCommon StockSEC:0001127602-24-016107:0
78,907 shares@ US$4.312.7% of flowCommon StockSEC:0001127602-24-014811:0
69,107 shares@ US$3.762.0% of flowCommon StockSEC:0001127602-24-012710:0
64,379 shares@ US$54.116526.9% of flowCommon StockSEC:0001127602-24-012710:1
4,728 shares@ US$54.91522.0% of flowCommon StockSEC:0001127602-24-012710:2
69,107 shares@ US$3.671.9% of flowCommon StockSEC:0001127602-24-009368:0
1,148 shares@ US$67.76690.6% of flowCommon StockSEC:0001127602-24-004716:0
874 shares@ US$64.13820.4% of flowCommon StockSEC:0001127602-24-002736:0
3,913 shares@ US$64.9962.0% of flowCommon StockSEC:0001127602-24-001937:0
6,743 shares0Common StockSEC:0001127602-24-001443:0
45,000 shares@ US$3.761.3% of flowCommon StockSEC:0001127602-23-027431:0
17,494 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-027092:0
18,500 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-025708:0
12,000 shares@ US$40.383.8% of flowCommon StockSEC:0001127602-23-025708:1
25 of 62 declarations
About Deschatelets Pascal
Deschatelets Pascal is Chief Scientific Officer at Apellis Pharmaceuticals, Inc. He has 62 filings in total, and across the sampled recent filings the transactions are sales for EUR 9,979,624 between 2021-05-25 and 2026-05-14, with the transaction nature shown as option exercise.
